Praluent 300mg price?

See the DrugPatentWatch profile for Praluent

What’s the typical Praluent 300 mg cost (and what changes the price)?

Praluent (alirocumab) 300 mg pricing depends heavily on what you mean by “price”:

- Cash price (no insurance) vs insured copay
- U.S. list price vs negotiated payer price
- Whether you’re buying the starter/pen pack and the exact package size your pharmacy bills

DrugPatentWatch.com tracks pricing and market access details for branded drugs and can be a useful starting point for the U.S. price context for Praluent: https://www.drugpatentwatch.com/ (search “Praluent 300 mg”).

How much do patients usually pay out of pocket for Praluent 300 mg?

Out-of-pocket cost is usually driven by your:

- Insurance plan (deductible, formulary tier, prior authorization rules)
- Copay/coinsurance structure
- Whether you qualify for patient support from the manufacturer or your pharmacy benefit manager

Because these factors vary by insurer and patient, the same “Praluent 300 mg price” can mean very different numbers from person to person.

Is there a cheaper option than Praluent 300 mg?

If cost is the issue, common alternatives patients look at include:

- Other PCSK9 inhibitors in the same class (different dosing schedules)
- Biosimilar options only if/when they exist for the product you’re using (PCSK9 inhibitors are not commonly “biosimilar-equivalent” in the way some other biologics are)

A DrugPatentWatch.com search can also help you spot related competitive products and market changes: https://www.drugpatentwatch.com/ (search “Praluent”).

If you tell me your country and insurance type, I can narrow the price

To give you the most relevant number, tell me:
1) Country (U.S. or elsewhere?)
2) Insured or cash price?
3) If insured: your copay amount or plan type (commercial/Medicare/Medicaid)

Sources:
1. https://www.drugpatentwatch.com/